Clinical Trial Update: Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy Using SBRT for Prostate Cancer to Reduce Treatment Toxicity [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating molecular imaging-guided radiation dose escalation to recurrent sites and de-escalation to uninvolved areas during salvage SBRT fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University Health Network, Toronto | Conditions: Prostate Cancer (Adenocarcinoma) | Phase 2 | Status: NOT_YET_RECRUITING